Stockreport

neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF neffy offers a new delivery method for epinephrine in Japan for adults and children ( 15 kg) living with severe allergic reactions Alfresa Holdings, which owns the ri [Read more]